Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-01-23 00:00:00 ET · period of report 2025-01-23 · accession 0001415889-25-002003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-23 | 2025-01-23 | TVTX | Baynes Roy D. | Dir | M - OptEx | $17.50 | +16.0K | 47.0K | +52% | +$280.0K |
| D | 2025-01-23 | 2025-01-23 | TVTX | Baynes Roy D. | Dir | S - Sale+OE | $20.00 | -16.0K | 31.0K | -34% | -$320.0K |
| D | 2025-01-23 | 2025-01-23 | TVTX | Baynes Roy D. | Dir | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-23 | M | A | 16,000 | $17.50 | 47,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-23 | S | D | 16,000 | $20.00 | 31,000 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2025-01-23 | M | D | 16,000 | $0.00 | 0 | D | $17.50 · — to 2026-07-19 | 16,000 Common Stock | (F2) The stock option is fully vested and exercisable. |